Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 21

Results: 9

The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1.
Published in:
2022
By:
- Morris, Gavin E.;
- Denniff, Matthew J.;
- Karamanavi, Elisavet;
- Andrews, Sarah A.;
- Kostogrys, Renata B.;
- Bountziouka, Vasiliki;
- Ghaderi‐Najafabadi, Maryam;
- Shamkhi, Noor;
- McConnell, George;
- Kaiser, Michael A.;
- Carleton, Laura;
- Schofield, Christine;
- Kessler, Thorsten;
- Rainbow, Richard D.;
- Samani, Nilesh J.;
- Webb, Thomas R.;
- Ghaderi-Najafabadi, Maryam
Publication type:
journal article
Correction to "Potential type 2 diabetes mellitus drug HMPA promotes short-chain fatty acid production by improving carbon catabolite repression effect of gut microbiota".
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 21, p. 5012, doi. 10.1111/bph.15941
Publication type:
Article
Ionotropic P2X4 and P2X7 receptors in the regulation of ion transport across rat colon.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 21, p. 4992, doi. 10.1111/bph.15928
By:
- Ballout, Jasmin;
- Claßen, Rebecca;
- Richter, Katrin;
- Grau, Veronika;
- Diener, Martin
Publication type:
Article
Gene-dosage effect of Pfkfb3 on monocyte/macrophage biology in atherosclerosis.
Published in:
2022
By:
- Guo, Shuai;
- Li, Anqi;
- Fu, Xiaodong;
- Li, Zou;
- Cao, Kaixiang;
- Song, Mingchuan;
- Huang, Shuqi;
- Li, Ziling;
- Yan, Jingwei;
- Wang, Litao;
- Dai, Xiaoyan;
- Feng, Du;
- Wang, Yong;
- He, Jun;
- Huo, Yuqing;
- Xu, Yiming
Publication type:
journal article
Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG‐CoA reductase inhibition.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 21, p. 4941, doi. 10.1111/bph.15893
By:
- Lindsay, Chris;
- Musgaard, Maria;
- Russell, Angela J.;
- Sitsapesan, Rebecca
Publication type:
Article
Issue Information.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 21, p. 4897, doi. 10.1111/bph.15564
Publication type:
Article
GPCRs as an emerging host‐directed therapeutic target against mycobacterial infection: From notion to reality.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 21, p. 4899, doi. 10.1111/bph.15315
By:
- Naz, Farha;
- Arish, Mohd
Publication type:
Article
The oxysterome and its receptors as pharmacological targets in inflammatory diseases.
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 21, p. 4917, doi. 10.1111/bph.15479
By:
- Guillemot‐Legris, Owein;
- Muccioli, Giulio G.
Publication type:
Article
Can the hyperthermia‐mediated heat shock factor/heat shock protein 70 pathway dampen the cytokine storm during SARS‐CoV‐2 infection?
Published in:
British Journal of Pharmacology, 2022, v. 179, n. 21, p. 4910, doi. 10.1111/bph.15343
By:
- Rébé, Cédric;
- Ghiringhelli, François;
- Garrido, Carmen
Publication type:
Article